Mediar Therapeutics

Mediar Therapeutics

Biotechnology Research

Boston, Massachusetts 2,775 followers

Mediar Therapeutics is a preclinical stage biotech company developing medicines to halt, or even reverse, fibrosis.

About us

Mediar Therapeutics is a biotechnology company pioneering a new approach to fibrosis treatment that halts the disease at a different source – the fibrotic mediators that drive disease progression. Mediar was founded based on a deep understanding of the complex science underlying fibrosis onset and progression. By combining novel targets with reliable, easily detectable blood biomarkers and familiar modalities, Mediar is derisking the path forward for fibrosis therapies in clinical development. For more information, contact info@mediartx.com

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Boston, Massachusetts
Type
Privately Held
Founded
2019

Locations

Employees at Mediar Therapeutics

Updates

Similar pages

Funding